Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) For Elderly (menos ou igual a 60 menos de 75years) Patients With Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Eligible For Allogeneic Stem Cell Transplantation: final report of VEN DEC GITMO study
